NASDAQ · PLSE
Pulse Biosciences, Inc
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PLSE: Nov 05, 2026
Pulse Biosciences, Inc Common Stock (DE) is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.35. The reported EPS for the same quarter last year was $-0.29.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Dec 2026 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Mar 2027 | $-0.35 | $-0.35 | $-0.35 | 1 |
| Jun 2027 | $-0.35 | $-0.35 | $-0.35 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · RTTNews · The Motley Fool- Zacks · Oct 29, 4:15 PM EDTDexCom (DXCM) Surpasses Q3 Earnings and Revenue EstimatesDexCom (DXCM) delivered earnings and revenue surprises of +10.61% and +1.64%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Fintel · Oct 23, 3:14 AM EDTPulse Biosciences Consensus Price Target Increased by 15.43% to $63.58The average one-year price target for Pulse Biosciences (NASDAQCM:PLSE) (DB:6L8) has been revised to $63.58 / share. This is an increase of 15.43% from the prior estimate of $55.08 dated September 29, 2026. These figures represent aggregate analyst targets compiled by Fintel, not
- RTTNews · Oct 14, 8:41 AM EDTPulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule Treatment(RTTNews) – Pulse Biosciences, Inc. (PLSE) has entered into a commercial and clinical partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida, aimed at expanding access to its nPulse Vybrance System for patients with benign thyroid nodu
- Fintel · Sep 15, 8:37 PM EDTPulse Biosciences Consensus Price Target Increased 12.27% to $51.82The average one-year price target for Pulse Biosciences (NASDAQCM:PLSE) has been revised to $51.82 / share. This is an increase of 12.27% from the prior estimate of $46.16 dated August 25, 2026. These figures represent the aggregate consensus of analyst targets and do not constit
- The Motley Fool · Sep 9, 7:44 PM EDTWhy Pulse Biosciences Stock Popped TodayAn analyst initiated coverage with an unambiguous buy recommendation.
- RTTNews · Sep 9, 2:36 PM EDTClinical Catalysts Drive Biotech Movers: Opus Genetics, Quantum & More(RTTNews) – Biotech and medical device stocks saw notable moves Wednesday, led by Opus Genetics, which surged more than 27% following positive clinical data. Quantum BioPharma gained after receiving FDA clearance for a Phase 2 MS trial, while Pulse Biosciences rallied more than 1
- Fintel · Sep 9, 2:19 PM EDTFreedom Capital Markets Initiates Coverage of Pulse Biosciences with a Buy RatingFintel reports that on September 9, 2026, Freedom Capital Markets initiated coverage of Pulse Biosciences (NASDAQCM:PLSE) with a Buy recommendation. Pulse Biosciences, Inc. is a U.S.-based company operating within the biomedical sector, specifically focused on developing therapeu
- RTTNews · Sep 8, 11:31 PM EDTBiotech Movers: Modular Medical Jumps, InnovAge Revenue Up 16%, Pyxis Data On Deck, Dogwood In Focus(RTTNews) – With heightened trade tensions between the U.S. and Canada and rising oil prices weighing on investor sentiment, U.S. stocks came under pressure on Tuesday. Against this backdrop, the SPDR S&P Biotech ETF (XBI), a broad benchmark for the U.S. biotechnology sector, dec
- BNK Invest · Sep 4, 1:34 PM EDTFriday 9/4 Insider Buying Report: UAMY, PLSEBargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today
- RTTNews · Sep 2, 3:34 AM EDTBiotech Stocks At 52-Week Highs – MMED +10%, PLSE, SOLV, RPRX, APGE(RTTNews) – The following biotech stocks reached a 52-week high on September 1, 2026, as various companies reported financial results and reached certain regulatory milestones.
- Barchart · Aug 18, 2:47 PM EDTStocks Settle Lower on Rising Crude Prices and Higher Bond YieldsThe S&P 500 Index ($SPX ) (SPY ) closed down by -0.52% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.17%. E-mini S&P futures (ESU26 ) fell -0.48%, and September E-mini…
- Barchart · Aug 17, 7:28 PM EDTStock Indices Waver on Strength in Chipmakers vs Weakness in Software CompaniesThe S&P 500 Index ($SPX ) (SPY ) is down by -0.15% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.28%. E-mini S&P futures (ESU26 ) are down -0.17%, and September E-mini…
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Pulse Biosciences, Inc from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.